| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 135 | 134 | 175 | 1.031 | 65.280 | 224.060 | 306.699 | 360.980 | 60.569 | 24.947 |
| Total Income - EUR | 135 | 134 | 175 | 1.031 | 75.912 | 230.539 | 357.622 | 403.523 | 111.934 | 87.722 |
| Total Expenses - EUR | 46 | 289 | 0 | 824 | 74.255 | 226.800 | 268.607 | 388.679 | 110.735 | 65.910 |
| Gross Profit/Loss - EUR | 89 | -156 | 175 | 208 | 1.657 | 3.739 | 89.015 | 14.844 | 1.199 | 21.813 |
| Net Profit/Loss - EUR | 85 | -160 | 170 | 177 | 993 | 1.586 | 86.451 | 11.549 | 553 | 19.518 |
| Employees | 0 | 0 | 0 | 0 | 2 | 4 | 4 | 4 | 2 | 1 |
Check the financial reports for the company - Bioverse S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 158.022 | 156.410 | 153.764 | 185.904 | 220.773 | 226.987 | 273.730 | 246.356 | 196.282 | 199.309 |
| Current Assets | 176.261 | 174.294 | 171.515 | 176.398 | 228.057 | 269.427 | 349.775 | 271.321 | 292.022 | 248.204 |
| Inventories | 0 | 0 | 0 | 18 | 34.414 | 49.485 | 94.752 | 32.829 | 63.680 | 79.115 |
| Receivables | 175.825 | 174.012 | 171.034 | 174.436 | 188.621 | 211.507 | 244.268 | 207.886 | 216.177 | 139.053 |
| Cash | 436 | 282 | 480 | 1.944 | 5.022 | 8.435 | 10.754 | 30.605 | 12.165 | 30.035 |
| Shareholders Funds | 176.309 | 174.351 | 171.570 | 168.599 | 166.326 | 164.759 | 247.557 | 219.318 | 219.206 | 237.499 |
| Social Capital | 10.439 | 10.332 | 10.157 | 9.971 | 9.778 | 9.593 | 9.380 | 9.409 | 9.380 | 9.328 |
| Debts | 157.974 | 156.354 | 153.708 | 193.703 | 282.505 | 331.655 | 375.948 | 298.359 | 269.098 | 210.015 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4634 - 4634" | |||||||||
| CAEN Financial Year |
1031
|
|||||||||
Comments - Bioverse S.r.l.